New US estimate links obesity to 18% of deaths.

August 27, 2013

Source: NHS Choices: Behind the Headlines

Follow this link for full text.

Date of publication: 16th August, 2013.

Publication type: Journal article.

In a nutshell: A closer look at the research behind recent headlines which suggested that obesity is killing more people than thought.

Length of publication: 1 webpage.

Some important notes: Follow this link to read the full text of the original research discussed in this article.

 


Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial.

September 16, 2011

Title: Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial.

Source: Obesity, 2011, 19 (9) p.1796-1803.

Follow this link for abstract.

Date of publication: September, 2011.

Publication type: Research.

In a nutshell: This study examines the effects of a 24-week weight loss program with Orlistat 60mg upon participants’ visceral adipose tissue (VAT) in comparison with placebo.  Whilst all participants had significantly reduced their VAT, those taking Orlistat also displayed a greater total fat mass loss and reduction in their intramuscular adipose tissue and liver fat content.  These results suggest that Orlistat 60mg may be an effective weight loss tool, particularly in relation to abdominal obesity.

Length of publication: 8 pages.

Some important notes: Please contact your local NHS Library for the full text of the article. Follow this link to find your local NHS Library.